Original Paper | 13-September-2016
Objective. To assess whether lymph node enlargement in the hepatoduodenal ligament occurs in children with chronic viral hepatitis B and C in comparison to healthy controls.Subject and methods. In 49 patients with chronic viral hepatitis (38 with chronic hepatitis B, 11 with chronic hepatitis C, 31 male, 18 female; age range 1 to 17 years),and in 51 healthy controls (25 male, 26 female; age range 4 to 16 years), the total perihepatic lymph node volume was assessed using transabdominal
Dagmar Schreiber-Dietrich,
Margret Pohl,
Xin-Wu Cui,
Barbara Braden,
Christoph F. Dietrich,
Liliana Chiorean
Journal of Ultrasonography, Volume 15 , ISSUE 61, 137–150
original-paper | 03-September-2019
Introduction
Hepatitis B virus (HBV) affects more than 2 billion people worldwide and approximately 247 million chronic individuals are known to be chronic carriers (Caligiuri et al. 2016; WHO 2018). HBV can cause severe liver infections and cirrhosis may develop in 15–40% of individuals if they are not treated (Tang et al. 2018). There are several novel treatment strategies that have been used for the treatment of chronic hepatitis B infection in order to prevent the risk of developing liver
AYSE ARIKAN,
MURAT SAYAN,
TAMER SANLIDAG,
KAYA SUER,
SINEM AKCALI,
MERYEM GUVENIR
Polish Journal of Microbiology, Volume 68 , ISSUE 3, 317–322
mini-review | 27-December-2020
Introduction
Although there are effective vaccines and treatment strategies against hepatitis B (HB), it is still a significant health concern worldwide that can present in acute, permanent, severe liver failure and cancer forms resulting in high morbidity and death. Globally, 2 billion people have been infected with HB. There is an estimated more than 292 million people living with chronic hepatitis B (CHB) infection worldwide. The global HB surface antigen (HBsAg) positivity was estimated to
MERYEM GUVENIR,
AYSE ARIKAN
Polish Journal of Microbiology, Volume 69 , ISSUE 4, 391–399